Curaleaf Laboratories’ sponsorship forms part of its ongoing collaboration with the MCCS.
Researchers say they are working to get two long-awaited NHS clinical trials underway to investigate the role of cannabis-based medicines in severe forms of epilepsy.
The number of items prescribed in the UK’s private medical cannabis market has doubled each year since 2021.
The Ministry of Health believes more research is needed before millions living with PTSD can access the treatment.
Synthetic THC (dronabinol) was well tolerated by patients without adverse effects seen from current medications.
Spanish regulators have taken another step towards introducing its long-delayed medical cannabis framework.
A new paper highlights how current policies, and a lack of training for professionals, are contributing to a range of harms.
A large percentage of people in their 50s and older have consumed at least one form of cannabis in the past year, a new US poll...
The study is thought to be among the first to examine long-term brain differences among patients using cannabis for medical symptoms.
The French ANSM assured at the beginning of the year that cannabis-based treatments would be available by 2025.
94% reported they consume cannabis for at least one medical or health reason.
